Ollie's had a mediocre quarter despite outperforming EPS and Same Store Sales estimates, as revenue missed and full-year guidance fell short. The company's stock fell 4.1% and future performance may be influenced by its valuation, business qualities, and recent results.
The market seems less excited about Ollie's Bargain Outlet Holdings than before, which could present an investment opportunity. The recent improvement in returns could suggest a positive shift within the business.
CEO notes strong closeout deal flow as consumers look to save on branded items, creating more opportunities. FY24 revenue estimated at $2.097B to $2.104B with an EPS of $2.77 to $2.83, outpacing consensus estimate.
CEO John Swygert expresses positive sentiments on Ms. Baglivo's appointment, stating that they're seeking to benefit from her extensive marketing and advertising experience and overall business acumen for executing their growth strategies and building the Ollie's brand.
Despite market incorporating OLLI's future growth, the stock appears steep due to high P/E ratio. Potential investors might find the current price prohibitive, while shareholders may consider selling, assuming stock should trade below current price due to high industry P/E ratio.
Q2 results impacted individual stocks with Ollie's, Nordstrom, Five Below, Dillard's, and Macy's witnessing a drop. Ollie’s improved outlook could lift its share price, while Nordstrom and Dillard's showed resilience. Macy's and Five Below's performance fell short, causing investor worry due to Macy's weaker annual guidance.
Gapping up $惠普(HPQ.US)$+2.6% (JPMorgan upgraded computer builder to overweight from neutral, saying it expects the PC industry to see upward revisions for the second half of this year. JPMorgan also downgraded Dell to neutral from overweight, citing its preference for HP's expected recovery, as Dell's PC segment will likely be offset by other factors. ) $Prometheus Biosciences(RXDX.US)$+69% (The company will be acquired by$默沙东(MRK.US)$for $10.8...
Ollie's Bargain Outlet股票讨论区
2024Q1营收增长12.9%,营业利润增长1.2倍,净利润增长1.5倍。
目前市盈率42,市盈率TTM已经降到了35.6,如果全年净利润达到2021年的2.4亿,相当于1季度净利润的8倍,那么市盈率将降到18,如果达到1季度的6倍,对应市盈率为24,看起来似乎还不错,不过仅有一个月的暴增数据是不够的,可以多等几份财报再做判断。
专栏Today's Pre-Market Stock Movers: HPQ, GOOGL, WOLF, RXDX and More
$惠普(HPQ.US)$ +2.6% (JPMorgan upgraded computer builder to overweight from neutral, saying it expects the PC industry to see upward revisions for the second half of this year. JPMorgan also downgraded Dell to neutral from overweight, citing its preference for HP's expected recovery, as Dell's PC segment will likely be offset by other factors. )
$Prometheus Biosciences(RXDX.US)$ +69% (The company will be acquired by $默沙东(MRK.US)$ for $10.8...
专栏Top upgrades and downgrades on 6/27: ETSY, CHWY, BBBY, GTLB and more
• $汽车地带(AZO.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $2,296 (from $1,969)
• $Chewy(CHWY.US)$ : Needham Upgrades to Buy from Hold - PT $55
• $National Vision(EYE.US)$ : Goldman Sachs Upgrades to Buy from Neutral - PT $32 (from $31)
• $费森尤斯医疗(FMS.US)$ : Jefferies Upgrades to Buy from Underperform - PT $33.70 (from $30.30)
• $Gitlab(GTLB.US)$ : Goldman Sachs Upgrades to Buy from Neutral - ...
暂无评论